Patients across Broward County — including Hollywood, Fort Lauderdale, Pembroke Pines, Hallandale Beach, Plantation, Davie, Coral Springs, and surrounding communities — are exploring physician-supervised GLP-1 treatment with semaglutide and tirzepatide for medical weight loss. Florida Surgery & Weight Loss Center offers telehealth consultations, prescription evaluations, insurance verification, and affordable self-pay options for eligible Florida patients.
🟢 Physician-supervised GLP-1 treatment available across Broward County, FL
🟢 Semaglutide and tirzepatide treatment for eligible patients
🟢 Brand-name medications may include Ozempic®, Wegovy®, Mounjaro®, and Zepbound®
🟢 Telehealth and in-office consultations available
🟢 Insurance verification for eligible patients
🟢 Affordable self-pay options for compounded medications
🟢 Prescriptions for brand-name GLP-1 medications may be sent to your preferred pharmacy
📞 (954) 551-3508 | Book Online
Florida Surgery & Weight Loss Center provides physician-supervised medical weight loss treatment for patients throughout Broward County, FL.
Cities served include:
Eligible patients may qualify for telehealth consultations and ongoing provider-supervised GLP-1 treatment from home.
Semaglutide and tirzepatide are GLP-1 medications used to support appetite control, portion management, and medically supervised weight loss.
Brand-name medications may include:
When clinically appropriate, prescriptions for brand-name medications may be sent directly to your preferred pharmacy.
Affordable self-pay options for compounded semaglutide and compounded tirzepatide may also be available for eligible patients.
“Successful medical weight loss should be personalized, medically supervised, and realistic for long-term health improvement. GLP-1 medications can be an important tool when combined with proper follow-up and lifestyle support.”
— Dr. Sergey Terushkin, MD, FACS📍 Florida Surgery & Weight Loss Center
1911 Harrison Street
Hollywood, FL 33020 📞 (954) 551-3508
“Many patients are looking for flexible treatment options that fit their schedule and health goals. Telehealth consultations and ongoing support can help make medical weight loss more accessible across Broward County.”
— Karla K. Mioduchoski, FNP-BC
Insurance coverage for semaglutide and tirzepatide depends on diagnosis, medical eligibility, and individual insurance plans.
Some patients may qualify for coverage of brand-name medications such as:
During your consultation, our team may help review your insurance benefits and discuss available treatment options.
Patients without insurance coverage may still qualify for affordable self-pay treatment programs.
Programs may include:
Compounded tirzepatide and semaglutide are not FDA-approved and may be prescribed when medically appropriate for eligible patients. Medications are prepared by licensed 503A compounding pharmacies based on an individual prescription and medical evaluation.
Patients may use semaglutide and tirzepatide treatment to support:
Treatment plans are personalized for each patient.
Like all prescription medications, GLP-1 treatments may cause side effects in some patients.
“Most patients tolerate treatment very well, but some may experience nausea, constipation, bloating, or fatigue during the first few weeks. In many cases, symptoms improve as the body adjusts to treatment.”
— Dr. Sergey Terushkin, MD, FACS
Patients across Broward County may qualify for convenient telehealth appointments from home.
Telehealth services may include:
When medically appropriate, prescriptions for Ozempic®, Wegovy®, Mounjaro®, and Zepbound® may be sent directly to your preferred pharmacy.
Our providers work with patients to help determine appropriate treatment options based on medical history, weight loss goals, and insurance eligibility.
Yes. Eligible patients across Broward County may qualify for telehealth or in-office GLP-1 treatment programs.
Brand-name medications may include Ozempic®, Wegovy®, Mounjaro®, and Zepbound® when clinically appropriate.
Yes. Affordable self-pay options may be available for compounded semaglutide and tirzepatide treatment.
Yes. Prescriptions for eligible patients may be sent to a preferred local pharmacy.
Insurance coverage varies based on diagnosis, medical eligibility, and insurance plan.
Compounded semaglutide and tirzepatide are not FDA-approved and, when prescribed, are prepared by licensed 503A compounding pharmacies for eligible patients.
Prescription weight loss treatment is provided only after medical evaluation and may not be appropriate for all patients. Brand-name medications such as Ozempic®, Wegovy®, Mounjaro®, and Zepbound® may be prescribed when clinically appropriate. Individual results may vary. In emergencies, call 911 or seek immediate medical care.
Real people, REAL RESULTS! Check out a few of the many people that we have helped reach their ideal weight goals over the years.
